INNOVANCE D-Dimer assay
Innovation in D-dimer testing that goes beyond the expected
The INNOVANCE® D-Dimer assay is an automated, particle-enhanced, immunoturbidimetric assay for the quantitative determination of cross-linked fibrin degradation products (D-dimers). The INNOVANCE D-Dimer assay is indicated for use in conjunction with a clinical pretest probability (PTP) assessment model to exclude deep vein thrombosis (DVT) and pulmonary embolism (PE) in outpatients suspected of DVT or PE. In addition, the INNOVANCE D‑Dimer assay can be used as an aid in diagnosis and monitoring of hypercoagulable states in patients at risk or with signs of disseminated intravascular coagulopathy (DIC) or other disorders associated with a hypercoagulability.1
Features & Benefits
Excellent clinical performance
- NEW! For use in DIC assessment. Cutoffs:1,2 Increased (2 points): 4.0 mg/L FEU, strongly increased (3 points): 13.0 mg/L FEU.
- Validated negative predictive value of ≥99.5% allows exclusion of DVT and PE, using a cut-off of 0.5 mg/L FEU across Siemens Healthineers and Sysmex systems.3,4
- Proven performance evaluated and verified across 24 sites and > 3300 samples (number of outpatients suspected of PE:1834 and DVT:1539), and under a set of inclusion/exclusion criteria reflecting real-life conditions.
- Excellent clinical performance permits a broader spectrum of clinical diagnosis, monitoring, and follow-up.
Fast turnaround time
- Fast turnaround time (11 minutes or less) improves daily throughput to enhance efficiency.
- Efficient, fully automated processing for reduced manual preparation and sample dilution.
Stable reagents
- Calibration curve stability of up to 12 months.
- Assay robustness combined with clinical efficiency eliminates the need for a dedicated D-dimer testing system.
Technical Specifications
INNOVANCE D-Dimer assay kit components
The assay consists of several components and can be ordered as a test kit.
INNOVANCE D-Dimer Buffer
Description: Buffered solution with stabilizers (ready-to-use liquid)
Available on a broad range of analyzers
INNOVANCE D-Dimer assay applications are available on BCS XP System, CN-3000/60001, CS-2500/5100, and CA-660 Systems. For details on available assay applications or order information, download a copy of the hemostasis reagent portfolio catalog.
Clinical Use
D-dimer testing—a cornerstone in your coagulation lab
D-dimer testing is a cornerstone of the coagulation lab. Besides its most important clinical use — the exclusion of venous thromboembolism (VTE) — and all the factors influencing specificity and sensitivity of D-dimer assays, elevated D-dimer levels play a pivotal role in many other diseases and conditions, such as severe infections (e.g., COVID-19), and in a wide variety of pro-thrombotic diseases. The INNOVANCE D-Dimer assay can be applied in different clinical settings, such as, but not limited to:
The products/features/applications mentioned here are not commercially available in all countries and are subject to local regulations. Their future availability cannot be guaranteed. Not available for sale in the U.S.
Suzuki K, Wada H, Imai H, et al. A re-evaluation of the D-dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: communication from the SSC of the ISTH. J Thromb Haemost 2018;16:1442-4. https://doi.org/10.1111/jth.14134
De Moerloose P, Palareti G, Aguilar C, et al. A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism. Thromb Haemost. 2008;100:505-12. https://doi.org/10.1160/TH08-04-0202
May vary depending on type of analyzer used and mode of operation.
CLSI. Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline. CLSI document H59-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2011.
Favresse J, Lippi G, Roy P-M, et al. D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications. Crit Rev Clin Lab Sci. 2018;55:8,548-77.
Wells PS. Integrated strategies for the diagnosis of venous thromboembolism. J Thromb Haemost 2007;5:41-50.
Hamer HM, Stroobants AK, Bavalia R, et al. Diagnostic accuracy of four different D-dimer assays: a post-hoc analysis of the YEARS study. Thromb Res 2021;201:18-22. https://doi.org/10.1016/j.thromres.2021.02.003
Tripodi A, D-dimer testing in laboratory practice. Clin Chem. 2011;57:9,1256-62.
Product availability varies from country to country and is subject to varying regulatory requirements. Please contact your local Siemens Healthineers organization for further details.
